Vilin Bio Med Limited Receives In-Principle Approval for Equity Share Listing

Vilin Bio Med Limited Receives In-Principle Approval for Equity Share Listing​

Vilin Bio Med Limited announced it has received in-principle approval from the National Stock Exchange for the listing of equity shares. The approval pertains to 13,00,000 shares, representing thirteen lakhs, that were previously allotted on a preferential basis. These shares have a face value of Rs. 10 each.

The in-principle approval was received on March 30, 2026.

Madhusudhan Yadamakanti Reddy, Managing Director, confirmed the receipt of the approval. Vilin Bio Med Limited’s website is www.vilinbio.com.

Source:​

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.